Nutraceuticals: Is there good science behind the hype?

British Journal of Clinical Pharmacology

Volumn 75, Issue 3, 2013, Pages 585-587

  Schmitt, Jeroen ^a,b   Ferro, Albert ^c  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUTRACEUTICAL; TRACE ELEMENT;

DRUG MARKETING; EDITORIAL; ENERGY RESOURCE; EVIDENCE BASED MEDICINE; HUMAN; LIFESTYLE; MACRONUTRIENT; NONHUMAN; PRIORITY JOURNAL; SAFETY; TRADITIONAL MEDICINE;

DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; HUMANS; PREVENTIVE MEDICINE; SCIENCE;

EID: 84873466139     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12061     Document Type: Editorial

References (18)

1. DeFelice ST. The nutraceutical revolution: its impact on food industry R&D. Trends in Food Science & Technology 1995; 6: 59-61.
2. Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013; 75: 603-618.
3. Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013; 75: 630-636.
4. European Union. Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union. L 404 of 30 December 2006.
5. Neale C, Camfield D, Reay J, Stough C, Scholey A. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes. Br J Clin Pharmacol 2013; 75: 728-737.
6. Mingrone G, Castagneto-Gissey L, Macé K. Use of dicarboxylic acids in type 2 diabetes. Br J Clin Pharmacol 2013; 75: 671-676.
7. Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 2013; 75: 645-662.
8. Nehlig A. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Br J Clin Pharmacol 2013; 75: 716-727.
9. Sacco SM, Horcajada M-N, Offord E. Phytonutrients for bone health during ageing. Br J Clin Pharmacol 2013; 75: 697-707.
10. Lidder S, Webb AJ. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol 2013; 75: 677-696.
11. Halliwell B. The antioxidant paradox, less paradoxical now? Br J Clin Pharmacol 2013; 75: 637-644.
12. Maidens C, Childs C, Przemska A, Bin Dayel I, Yaqoob P. Modulation of vaccine response by concomitant probiotic administration. Br J Clin Pharmacol 2013; 75: 663-670.
13. Welch RW, Antoine JM, Berta JL, Bub A, de Vries J, Guraner F, Hasselwander O, Hendriks H, Jäkel M, Koletzko BV, Patterson CC, Richelle M, Skarp M, Theis S, Vidry S, Woodside JV. Guidelines for the design, conduct and reporting of human interventions studies to evaluate the health benefits of foods. Br J Nutr 2011; 106: S4-S15.
14. Rein MJ, Renouf M, Cruz-Hernandez C, Actis-Goretta L, Thakkar SK, da Silva Pinto M. Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br J Clin Pharmacol 2013; 75: 588-602.
15. Breen L, Phillips SM. Interactions between exercise and nutrition to prevent muscle waste during ageing. Br J Clin Pharmacol 2013; 75: 708-715.
16. Gillette-Guyonnet S, Secher M, Vellas B. Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol 2013; 75: 738-755.
17. Collino S, Martin F-PJ, Rezzi S. Clinical metabolomics paves the way towards future healthcare strategies. Br J Clin Pharmacol 2013; 75: 619-629.
18. Schmitt JAJ. Nutrition and cognition: meeting the challenge to obtain credible and evidence-based facts. Nutr Rev 2010; 68: S2-S5.